To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more


Latest news

View all news

Help us understand how you assess kidney function in cancer patients and how you dose reduce anti-cancer drugs in patients with kidney dysfunction. Please complete our short 10 minute survey. Open until Friday 2 July 2021.

With the change in biosimilar brand of bevacizumab available on the PBS from 1 June 2021, eviQ is collecting information on how bevacizumab is being administered in clinical practice with the view to inform the update of eviQ protocols in the future. Please take our short 5 minute survey open until 30 June 2021.

Access exclusive eviQ Education content and take the new oncological emergencies mini quizzes via our new app! Track your learning, earn CPD points, download certificates and more!

Expressions of interest are invited for two eviQ Medical Oncology Reference Committee Co-Chairs. Click the link to find out details. EOIs close by COB Thursday 1st July 2021.